Discovery shows how to treat heart attacks; drug development underway

by: Research News @ Vanderbilt

Appello Pharma completes Series A to advance treatment of Parkinson's

by: VNC Venture Nashville Connections

VU319 Shows Safe Profile and Potential as M1 Allosteric Modulator for MCI

by: Marco Meglio
NeurologyLive

Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer's patients

by: Vanderbilt News

Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders

by: Ryan Underwood
Research News @ Vanderbilt